From Wikipedia, the free encyclopedia
Chemical compound
Lurosetron
![](https://upload.wikimedia.org/wikipedia/commons/thumb/1/1f/Lurosetron.png/220px-Lurosetron.png) |
|
ATC code | |
---|
|
6-fluoro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
|
CAS Number | |
---|
PubChem
CID | |
---|
ChemSpider | |
---|
UNII | |
---|
KEGG | |
---|
CompTox Dashboard (
EPA) | |
---|
|
Formula | C17H17FN4O |
---|
Molar mass | 312.348 g·mol−1 |
---|
3D model (
JSmol) | |
---|
CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=C(N3C)C(=CC=C4)F
|
InChI=1S/C17H17FN4O/c1-10-13(20-9-19-10)8-22-7-6-14-15(17(22)23)11-4-3-5-12(18)16(11)21(14)2/h3-5,9H,6-8H2,1-2H3,(H,19,20) NKey:NUMKWGDDRWJQMY-UHFFFAOYSA-N N
|
N Y
(what is this?)
(verify) |
Lurosetron (
INN) is a
serotonin
5-HT3 receptor antagonist.
[1]
Synthesis
Lurosetron synthesis
[2]
References
-
^ Prakash SP, Cable KM, Correa ID, Fellows L, Montgomery S, Newman JJ, Waterhouse L, Wells GN, Sutherland DR (1995). "Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists". Journal of Labelled Compounds and Radiopharmaceuticals. 36 (10): 993–1007.
doi:
10.1002/jlcr.2580361011.
-
^
EP 0353983, Coates, Ian Harold; Oxford, Alexander William & North, Peter Charles et al., published 1990-02-07, assigned to
Glaxo Group Ltd.